|
1.
|
Lee HK, Choi YS, Park YA and Jeong S:
Modulation of oncogenic transcription and alternative splicing by
β-catenin and an RNA aptamer in colon cancer cells. Cancer Res.
66:10560–10566. 2006.
|
|
2.
|
Casey G, Lindor NM, Papadopoulos N,
Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins
CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR,
Hopper JL, Diep A, Bapat B, Salem M and Seminara D: Conversion
analysis formutation detection in MLH1 and MSH2 in patients with
colorectal cancer. JAMA. 293:799–809. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hung KE and Chung DC: New insights into
the molecular pathogenesis of colorectal cancer. Drug Discov Today
Dis Mech. 3:439–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bartel DP: MicroRNAs: genomic, biogenesis,
mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Gregory RI, Yan KP, Amuthan G, Chendrimada
T, Doratotaj B, Cooch N and Shiekhattar R: The microprocessor
complex mediates the genesis of microRNAs. Nature. 432:235–240.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of microRNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
Mitsudomi T and Takahashi T: Reduced expression of the let-7
microRNAs in human lung cancers in association with shortened
postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar
|
|
10.
|
Nagel R, Le Sage C, Diosdado B, van der
Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
12.
|
Valeri N, Croce CM and Fabbri M:
Pathogenetic and clinical relevance of microRNAs in colorectal
cancer. Cancer Genomics Proteomics. 6:195–204. 2009.PubMed/NCBI
|
|
13.
|
Toyoshima T, Kamijo R, Takizawa K,
Sumitani K, Ito D and Nagumo M: Inhibitor of cyclooxygenase-2
induces cell-cycle arrest in the epithelial cancer cell line via
up-regulation of cyclin dependent kinase inhibitor p21. Br J
Cancer. 6:1150–1156. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Johnson AJ, Hsu AL, Lin HP, Song X and
Chen CS: The cyclooxygenase-2 inhibitor celecoxib perturbs
intracellular calcium by inhibiting endoplasmic reticulum
Ca2+-ATPases: a plausible link with its antitumor effect
and cardiovascular risks. Biochem J. 366:831–837. 2002.PubMed/NCBI
|
|
15.
|
Zhu J, Huang JW, Tseng PH, Yang YT, Fowble
J, Shiau CW, Shaw Y, Kulp SK and Chen CS: From the cyclooxygenase-2
inhibitor celecoxib to a novel class of
3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer
Res. 64:4309–4318. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Iorio MV, Manuela F, Liu CG, Angelo V,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I,
Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene
expression deregulation in human breast cancer. Cancer Res.
65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar
|
|
18.
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microNRA sequences, target
and gene nomenclature. Nucleic Acids Res. 34:140–144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Michael MZ, O’Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
20.
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Sarver AL, French AJ, Borralho PM,
Thayanithy V, Oberg AL, Bergemann TL, Gupta M, O’Sullivan MG,
Matise I, Dupuy AJ, et al: Human colon cancer profiles show
differential microRNA expression depending on mismatch repair
status and are characteristic of undifferentiated proliferative
states. BMC Cancer. 9:401–406. 2009. View Article : Google Scholar
|
|
22.
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Bandres E, Cubedo E, Agirre X, Malumbres
R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M and
Garcia-Foncillas J: Identification by real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and
non-tumoral tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6124. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
He L, Thomson JM, Hemann MT, Hernando-Mong
E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ
and Hammond SM: A microRNA polyistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Huang GL, Zhang XH, Guo GL, Huang KT, Yang
KY, Shen X, You J and Hu XQ: Clinical significance of miR-21
expression in breast cancer: SYBR-Green I-based real-time RT-PCR
study of invasive ductal carcinoma. Oncol Rep. 21:673–679.
2009.PubMed/NCBI
|
|
31.
|
Calin GA, Sevignani C, Ferrai JG, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Shen J, Ambrosone CB and Zhao H: Novel
genetic variants in microRNA genes and familial breast cancer. Int
J Cancer. 124:1178–1182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Zanette DL, Rivadavia F, Jacoby S,
Barbuzano FG, Proto-Siqueira R, Silva WA Jr, Falcao RP and Zago MA:
MiRNA expression profiles in chronic lymphocytic and acute
lymphocytic leukemia. Braz J Med Bio Res. 40:1435–1440. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Bussing I, Slack FJ and Grosshans H: Let-7
microRNAs in development stem cells and cancer. Trends Mol Med.
14:400–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Lee YS and Dutta A: The tumor suppressor
microRNA let-7 represses the HMGA2 oncogene. Genes Dev.
21:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Sampson VB, Rong NH, Han J, Yang Q, Aris
V, Soteropoulos P, Petrelli NJ, Dunn SP and Krueger LJ: MicroRNA
let-7a down regulates MYC and reverts MYC-induced growth in Burkitt
lymphoma cells. Cancer Res. 67:9762–9770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Meng F, Henson R, Iinuma M, Smith H, Ueno
Y and Patel T: The microRNA let-7a modulates interleukin-6
dependent STAT-3 survival signaling in malignant human
cholangiocytes. J Biol Chem. 282:8256–8264. 2007. View Article : Google Scholar : PubMed/NCBI
|
